Letter to Editor
BibTex RIS Cite

Year 2020, Volume: 2 Issue: 2, 49 - 50, 30.08.2020

Mehmet Murat Uzel

Abstract

References

  • 1) World Health Organization. Coronavirus disease (COVID-19) pandemic.https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  • 2) Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; Feb 26 [Epub ahead of print].
  • 3) Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE et al. Assessing viral Shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020 Mar 24. Pii: S0161-6420(20)30311-0.
  • 4) Wu P, Duan F, Luo C, Liu Q, Qu, X, Liang L et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020 Mar 31. Doi:10.1001/jamaophthalmol.2020.1291. [Epub ahead of print].
  • 5) Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013.
  • 6) Li C, Tang Y, Chen Z, Wang A, Huang X, Chen Y, et al. Aerosol formation during non-contact “air-puff” tonometry and its significance for prevention of COVID-19. Chin J Exp Ophthalmol. 2020;38(0):E010.

Glaucoma and Possible Risks During SARS-CoV-2 Pandemic

Year 2020, Volume: 2 Issue: 2, 49 - 50, 30.08.2020

Mehmet Murat Uzel

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to a rapid change worldwide. In ophthalmological examination, it was stated that the risk of virus transmission is high. For this reason, special protective equipment had to be put into use. In addition, proper sterilization of the instruments used in the examination and reorganization of the waiting room have gained importance. Nevertheless, it is recommended to postpone routine eye examinations except in emergencies. Glaucoma is a disease managed in the light of the findings obtained during routine examinations. Prolonged pandemic process may lead to irreversible optic nerve damage in patient groups that move away from routine examination.

Keywords

glaucoma covid-19

References

  • 1) World Health Organization. Coronavirus disease (COVID-19) pandemic.https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  • 2) Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; Feb 26 [Epub ahead of print].
  • 3) Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE et al. Assessing viral Shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020 Mar 24. Pii: S0161-6420(20)30311-0.
  • 4) Wu P, Duan F, Luo C, Liu Q, Qu, X, Liang L et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020 Mar 31. Doi:10.1001/jamaophthalmol.2020.1291. [Epub ahead of print].
  • 5) Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013.
  • 6) Li C, Tang Y, Chen Z, Wang A, Huang X, Chen Y, et al. Aerosol formation during non-contact “air-puff” tonometry and its significance for prevention of COVID-19. Chin J Exp Ophthalmol. 2020;38(0):E010.
There are 6 citations in total.

Details

Primary Language English
Subjects Ophthalmology
Journal Section Letter to The Editor
Authors

Mehmet Murat Uzel

Publication Date August 30, 2020
Acceptance Date July 1, 2020
Published in Issue Year 2020 Volume: 2 Issue: 2

Cite

APA Uzel, M. M. (2020). Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. Clinical and Experimental Ocular Trauma and Infection, 2(2), 49-50.
AMA Uzel MM. Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. CEOTI. August 2020;2(2):49-50.
Chicago Uzel, Mehmet Murat. “Glaucoma and Possible Risks During SARS-CoV-2 Pandemic”. Clinical and Experimental Ocular Trauma and Infection 2, no. 2 (August 2020): 49-50.
EndNote Uzel MM (August 1, 2020) Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. Clinical and Experimental Ocular Trauma and Infection 2 2 49–50.
IEEE M. M. Uzel, “Glaucoma and Possible Risks During SARS-CoV-2 Pandemic”, CEOTI, vol. 2, no. 2, pp. 49–50, 2020.
ISNAD Uzel, Mehmet Murat. “Glaucoma and Possible Risks During SARS-CoV-2 Pandemic”. Clinical and Experimental Ocular Trauma and Infection 2/2 (August 2020), 49-50.
JAMA Uzel MM. Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. CEOTI. 2020;2:49–50.
MLA Uzel, Mehmet Murat. “Glaucoma and Possible Risks During SARS-CoV-2 Pandemic”. Clinical and Experimental Ocular Trauma and Infection, vol. 2, no. 2, 2020, pp. 49-50.
Vancouver Uzel MM. Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. CEOTI. 2020;2(2):49-50.
 Download Cover Image

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License(CC BY-NC-SA 4.0)